188 related articles for article (PubMed ID: 25586721)
1. Structural dynamics of native and V260E mutant C-terminal domain of HIV-1 integrase.
Sangeetha B; Muthukumaran R; Amutha R
J Comput Aided Mol Des; 2015 Apr; 29(4):371-85. PubMed ID: 25586721
[TBL] [Abstract][Full Text] [Related]
2. The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study.
Balasubramanian S; Rajagopalan M; Bojja RS; Skalka AM; Andrake MD; Ramaswamy A
J Biomol Struct Dyn; 2017 Dec; 35(16):3469-3485. PubMed ID: 27835934
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of an oligomerization-negative mutant of HIV-1 integrase.
Kalpana GV; Reicin A; Cheng GS; Sorin M; Paik S; Goff SP
Virology; 1999 Jul; 259(2):274-85. PubMed ID: 10388652
[TBL] [Abstract][Full Text] [Related]
4. Structural dynamics of full-length retroviral integrase: a molecular dynamics analysis.
Balasubramanian S; Rajagopalan M; Ramaswamy A
J Biomol Struct Dyn; 2012; 29(6):659-70. PubMed ID: 22545997
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulations of the HIV-1 integrase dimerization interface: guidelines for the design of a novel class of integrase inhibitors.
Sippel M; Sotriffer CA
J Chem Inf Model; 2010 Apr; 50(4):604-14. PubMed ID: 20230013
[TBL] [Abstract][Full Text] [Related]
6. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
7. Biophysical analysis of the MHR motif in folding and domain swapping of the HIV capsid protein C-terminal domain.
Bocanegra R; Fuertes MÁ; Rodríguez-Huete A; Neira JL; Mateu MG
Biophys J; 2015 Jan; 108(2):338-49. PubMed ID: 25606682
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments.
Tintori C; Esposito F; Morreale F; Martini R; Tramontano E; Botta M
Bioorg Med Chem Lett; 2015 Aug; 25(15):3013-6. PubMed ID: 26048795
[TBL] [Abstract][Full Text] [Related]
9. Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies.
Deng N; Hoyte A; Mansour YE; Mohamed MS; Fuchs JR; Engelman AN; Kvaratskhelia M; Levy R
Protein Sci; 2016 Nov; 25(11):1911-1917. PubMed ID: 27503276
[TBL] [Abstract][Full Text] [Related]
10. Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding.
Lutzke RA; Plasterk RH
J Virol; 1998 Jun; 72(6):4841-8. PubMed ID: 9573250
[TBL] [Abstract][Full Text] [Related]
11. Identification of residues in the C-terminal domain of HIV-1 integrase that mediate binding to the transportin-SR2 protein.
De Houwer S; Demeulemeester J; Thys W; Taltynov O; Zmajkovicova K; Christ F; Debyser Z
J Biol Chem; 2012 Oct; 287(41):34059-68. PubMed ID: 22872638
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of a mutant of the HIV-1 integrase zinc finger domain that forms a single conformation.
Nomura Y; Masuda T; Kawai G
J Biochem; 2006 Apr; 139(4):753-9. PubMed ID: 16672276
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis and allosteric effects in the HIV-1 capsid protein carboxyl-terminal dimerization domain.
Yu X; Wang Q; Yang JC; Buch I; Tsai CJ; Ma B; Cheng SZ; Nussinov R; Zheng J
Biomacromolecules; 2009 Feb; 10(2):390-9. PubMed ID: 19199580
[TBL] [Abstract][Full Text] [Related]
14. A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase.
Shkriabai N; Dharmarajan V; Slaughter A; Kessl JJ; Larue RC; Feng L; Fuchs JR; Griffin PR; Kvaratskhelia M
J Biol Chem; 2014 Sep; 289(38):26430-26440. PubMed ID: 25118283
[TBL] [Abstract][Full Text] [Related]
15. Larger helical populations in peptides derived from the dimerization helix of the capsid protein of HIV-1 results in peptide binding toward regions other than the "hotspot" interface.
Doménech R; Bocanegra R; González-Muñiz R; Gómez J; Mateu MG; Neira JL
Biomacromolecules; 2011 Sep; 12(9):3252-64. PubMed ID: 21761887
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.
Topper M; Luo Y; Zhadina M; Mohammed K; Smith L; Muesing MA
J Virol; 2007 Mar; 81(6):3012-7. PubMed ID: 17182677
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.
Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA
J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724
[TBL] [Abstract][Full Text] [Related]
18. The dynamics of interconverting D- and E-forms of the HIV-1 integrase N-terminal domain.
Sangeetha B; Muthukumaran R; Amutha R
Eur Biophys J; 2014 Nov; 43(10-11):485-98. PubMed ID: 25106127
[TBL] [Abstract][Full Text] [Related]
19. N-terminal half of transportin SR2 interacts with HIV integrase.
Tsirkone VG; Blokken J; De Wit F; Breemans J; De Houwer S; Debyser Z; Christ F; Strelkov SV
J Biol Chem; 2017 Jun; 292(23):9699-9710. PubMed ID: 28356354
[TBL] [Abstract][Full Text] [Related]
20. Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase.
Lu R; Ghory HZ; Engelman A
J Virol; 2005 Aug; 79(16):10356-68. PubMed ID: 16051828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
